Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Arch Environ Occup Health ; 72(3): 153-158, 2017 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-27120705

RESUMEN

To investigate whether α-tocopherol supplementation in workers exposed to lead would reduce the oxidative stress intensity and decrease homocysteine level, the examined population was randomly divided into two groups. Workers in the first group (n = 49, reference group) were not administered any drugs. Workers in the second group (n = 34) were administered orally α-tocopherol, 200 mg per day for 12 weeks. The level of α-tocopherol significantly increased compared to the baseline and the reference group. The level of thiol groups significantly increased compared to the reference group. However, the levels of malondialdehyde and homocysteine did not significantly change. Animal studies suggest the ability of α-tocopherol administration to reverse adverse health effects of lead exposure, such as oxidative stress; however, the results of this study on humans do not confirm these protective effects.


Asunto(s)
Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Homocisteína/efectos de los fármacos , Intoxicación por Plomo/complicaciones , Exposición Profesional , Estrés Oxidativo/efectos de los fármacos , alfa-Tocoferol/administración & dosificación , alfa-Tocoferol/farmacología , Adulto , Homocisteína/sangre , Humanos , Persona de Mediana Edad
2.
Environ Toxicol Pharmacol ; 43: 175-81, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27002494

RESUMEN

The aim of the study was to investigate whether α-tocopherol supplementation for workers who are chronically exposed to lead would normalize/improve the values of parameters that are associated with the lead-induced oxidative stress. Study population included chronically lead exposed males who were divided into two groups. Workers in the first group (reference group) were not given any antioxidants, while workers in the second group (αT group) received supplementation with α-tocopherol. After treatment, the blood lead and leukocyte malondialdehyde levels decreased significantly in the αT group compared to the baseline levels and reference group. However, the erythrocyte malondialdehyde, conjugated dienes, and lipofuscin levels significantly increased compared to the baseline levels. The glutathione level significantly increased compared with the baseline. Effects of supplementation with α-tocopherol on oxidative damage were not satisfactory. Therefore, there is no reason to administer α-tocopherol to workers chronically exposed to lead as a prophylaxis of lead poisoning.


Asunto(s)
Antioxidantes/farmacología , Intoxicación por Plomo/tratamiento farmacológico , Exposición Profesional/estadística & datos numéricos , alfa-Tocoferol/farmacología , Suplementos Dietéticos , Glutatión/metabolismo , Humanos , Masculino , Malondialdehído/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA